![Stephen Thomas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Thomas
Director/Board Member at ELIEM THERAPEUTICS, INC.
Net worth: 801 123 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Andrew Levin | M | 47 | 6 years | |
Valerie Morisset | M | 55 | 6 years | |
Liam Ratcliffe | M | 60 | 5 years | |
Adam Rosenberg | M | 54 | 4 years | |
Simon Tate | M | 58 | 5 years | |
Judith Dunn | M | 62 | 3 years | |
Michael Solomon | M | 54 |
ValenzaBio, Inc.
![]() ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | 3 years |
Joanne Palmer | F | - | - | |
Emily Pimblett | F | 40 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Patrick Crutcher | M | 39 |
Ichorion Therapeutics, Inc.
![]() Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Thomas
- Personal Network